Ani Pharmaceuticals Inc (ANIP)

Pharmaceutical Preparations

Latest Price

$72.65

TTM P/E

15.79

Normalized P/E

639.05

Div Yield

Book Value

28.39

P/B Ratio

2.56

Valuation metrics

EPS: $3.32

Book value / share: $24.04

Formula: √(22.5 × EPS × BVPS)

Graham Number

$42.38

42% downside

Base FCF: $79M (median of recent 5yr)

Growth: -15%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$14.67

80% downside

EPS: $3.32

Target P/E: 16×

Formula: EPS × P/E

P/E Fair Value

$53.12

27% downside

100.0% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	2.96M	$244.0M	13.98%	+211.2K	2026-06-30
Soleus Capital Management, L.P.	867.8K	$71.0M	4.10%	+47.5K	2026-06-30
Vanguard Capital Management LLC	838.2K	$69.0M	3.96%	+15.2K	2026-06-30
State Street Corp	831.6K	$68.0M	3.93%	+60.1K	2026-06-30
Tang Capital Management LLC	707.5K	$58.0M	3.34%	--	2026-06-30
Dimensional Fund Advisors LP	623.5K	$51.0M	2.95%	+92.3K	2026-06-30
American Century Companies Inc	574.5K	$47.0M	2.72%	+382.9K	2026-06-30
Arrowstreet Capital, Limited Partnership	562.0K	$46.0M	2.66%	-2.3K	2026-06-30
Global Alpha Capital Management Ltd.	558.0K	$46.0M	2.64%	+196.8K	2026-06-30
Geode Capital Management, LLC	536.4K	$44.0M	2.54%	+47.2K	2026-06-30